Spironolactone Tablet
Product Images NDC 68071-3903

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3903 9)

This is a description of Spironolactone 100mg tablets manufactured by NuCare Pharmaceuticals, Inc. Each tablet contains Spironolactone USP 100mg and is round-shaped, biconvex, white to almost white. The tablets are debossed with "SP" above a score line and "100" below the score line. The product information includes the lot number, expiration date, and a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F. Additionally, patients are advised to consult their doctor for medical advice on potential side effects and can report any adverse effects to the FDA.*

FDA Label Image

Figure (Spironolactone Fig1)

This text provides statistical data comparing Spironolactone to a Placebo with respect to an outcome or variable labeled as "B" over a period of 18 to 24 months. The log-rank p-value is less than 0.0001, indicating a significant difference between the two groups. The study involved a sample of 822 individuals treated with Spironolactone and 841 individuals who received a Placebo.*

FDA Label Image

Fig2 (Spironolactone Fig2)

FDA Label Image

Str1 (Spironolactone Str1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.